CERVICOBRACHIAL SYNDROME: PREVALENCE AND CLINICAL CORRELATION WITH CORONAVIRUS 2019 DISEASE AMONG HOSPITALIZED PATIENTS
Abstract
There are currently emerging concerns about the multisystem involvement of the coronavirus disease 2019 (COVID-19) infection as well as potential long-term complications. The aim of our study was to examine the prevalence and clinical characteristics of cervicobrachial syndrome among hospitalized patients with COVID-19. The research was conducted as a prospective study on 147 patients with previously confirmed COVID-19 infection by using a Real-Time Polymerase Chain Reaction assay for SARS-Cov-2. After neurological assessment and meticulous patient history-taking, the patients were divided into a group with and a group without a previous history of cervicobrachialgia. The pain intensity was self-assessed by patients using a numerical scale ranging from 0 to 10, while routine laboratory analyzes related to COVID-19 were performed from venous blood samples. Our data demonstrate a statistically significant association between previous history and recurrence of cervicobrachialgia (LR = 28.655; p = 0.000). Moreover, the pain intensity assessment in patients with a previous history of cervicobrachialgia statistically significantly correlates with the current degree of cervicobrachialgia during hospitalization (p = 0.000). Furthermore, a weak positive correlation (r = 0.168; p = 0.046) was noted between the current degree of cervicobrachiialgia and the neutrophil to lymphocyte ratio. The present study demonstrates a statistically significant association between the previous history of cervicobrachial syndrome and its recurrence, as well as pain intensity assessment in hospitalized patients due to COVID-19. The neutrophil-to-lymphocyte ratio positively correlates with the degree of cervicobrachialgia and may indicate an increase in the local inflammatory response in cervicobrachial syndrome.
References
Alexander EP. History, physical examination, and differential diagnosis of neck pain. Phys Med Rehabil Clin N Am 2011;22(3):383–93. [CrossRef] [PubMed]
Bisgaard AK, Pihl-Jensen G, Frederiksen JL. The neutrophil-to-lymphocyte ratio as disease actvity marker in multiple sclerosis and optic neuritis. Mult Scler Relat Dis 2017;18:213-7. [CrossRef] [PubMed]
Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, Evaluation, and Treatment of Coronavirus (COVID- 19). StatPearls (serial online) 2022 Jun “cited 2023 October 10”. Available from: URL: https://www.ncbi.nlm.nih.gov/books/NBK554776/ [PubMed]
Demir B, Beyazyüz E, Beyazyüz M, Çelikkol A, Albayrak Y, et al. Long-lasting cognitive effects of COVID-19: Is there a role of BDNF? Eur Arch Psychiatry Clin Neurosci 2023;273(6):1339-47. [CrossRef] [PubMed]
Erben Y, Prudencio M, Marquez CP, Jansen-West KR, Heckman MG, White LJ, et al. Neurofilament light chain and vaccination status associate with clinical outcomes in severe COVID-19. IScience 2022;25(11):105272. [CrossRef] [PubMed]
Ethemoğlu KB, Erkoç YS. Is There Any Relationship Between Cervical Disc Herniation and Blood Inflammatory Response?. Cureus 2020;12(8): e10161. [CrossRef] [PubMed]
Frohlich J, Chaldakov GN, Vinciguerra M. Cardio- and Neurometabolic Adipobiology: Consequences and Implications for Therapy. Int J Mol Sci 2021;22(8):4137. [CrossRef] [PubMed]
Gangavelli R, Nair NS, Bhat AK, Solomon JM. Cervicobrachial pain - How Often is it Neurogenic? J Clin Diagn Res 2016;10(3):YC14-6. [CrossRef] [PubMed]
García-Grimshaw M, Hernández-Vanegas LE, Núñez I, Hernández-Valdivia N, Carrillo-García DA, Michel-Chávez A, et al. Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: a nationwide descriptive study. Clin Immunol 2021;229:108786. [CrossRef] [PubMed]
Garg M, Maralakunte M, Dhooria S. Sequelae of COVID-19 pneumonia: Is it correct to label everything as post-COVID lung fibrosis? J Postgrad Med 2021;67(4):224-7. [CrossRef] [PubMed]
Gelibter S, Pisa M, Croese T, Dalla Costa G, Orrico M, Preziosa P, et al. Neutrophil-to-lymphocyte ratio: a marker of neuro- inflammation in multiple sclerosis? J Neurol 2021;268(2):717-23. [CrossRef] [PubMed]
Hemond CC, Glanz BI, Bakshi R, Chitnis T, Healy BC. The neutrophil-to-lymphocyte and monocyte-to- lymphocyte ratios are independently associated with neurological disability and brain atrophy in multiple sclerosis. BMC Neurol 2019;19(1):23. [CrossRef] [PubMed]
Ilić J, Kostić A, Stojanović N, Djordjević M, Kostić E, Nikolov V, et al. Sciatica and lumbago in hospitalized COVID-19 patients. Acta Med Median 2023;62(1). [CrossRef]
Imtiaz F, Shafique K, Mirza SS, Ayoob Z, Vart P, Rao S. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med 2012;5(1):1-6. [CrossRef] [PubMed]
Marraro GA, Spada C. Understanding respiratory disease 'due to' or 'with' COVID-19 to assess appropriate treatment. J Postgrad Med 2022;68(4):194-6. [CrossRef] [PubMed]
Montalvan V, Lee J, Bueso T, De Toledo J, Rivas K. Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review. Clin Neurol Neurosurg 2020;194:105921. [CrossRef] [PubMed]
Norris ZA, Sissman E, O'Connell BK, Mottole NA, Patel H, Balouch E, et al. COVID-19 pandemic and elective spinal surgery cancelations–what happens to the patients?. Spine J 2021;21(12):2003-9. [CrossRef] [PubMed]
Parthasarathi A, Padukudru S, Arunachal S, Basavaraj CK, Krishna MT, Ganguly K, et al. The role of neutrophil-To-Lymphocyte ratio in risk stratification and prognostication of COVID-19: A systematic review and meta-analysis. Vaccines 2022;10(8):1233. [CrossRef] [PubMed]
Petrella C, Zingaropoli MA, Ceci FM, Pasculli P, Latronico T, Liuzzi GM, et al. COVID-19 Affects Serum Brain-Derived Neurotrophic Factor and Neurofilament Light Chain in Aged Men: Implications for Morbidity and Mortality. Cells 2023;12(4):655. [CrossRef] [PubMed]
Román GC, Gracia F, Torres A, Palacios A, Gracia K, Harris D, et al. Acute Transverse Myelitis (ATM): clinical review of 43 patients with COVID-19-associated atm and 3 post-vaccination atm serious adverse events with the chadox1 ncov-19 vaccine (AZD1222). Front Immunol 2021;12:653786 [CrossRef] [PubMed]
Sadowska A, Touli E, Hitzl W, Greutert H, Ferguson SJ, Wuertz-Kozak K, et al. Inflammaging in cervical and lumbar degenerated intervertebral discs: analysis of proinflammatory cytokine and TRP channel expression. Eur Spine J 2018;27(3):564-77. [CrossRef] [PubMed]
Shekhawat J, Gauba K, Gupta S, Purohit P, Mitra P, Garg M, et al. Interleukin-6 Perpetrator of the COVID-19 Cytokine Storm. Ind J Clin Biochem 2021;36(4):440-50. [CrossRef] [PubMed]
Shiri R, Solovieva S, Husgafvel-Pursiainen K, Telama R, Yang X, Viikari J, et al. The role of obesity and physical activity in non- specific and radiating low back pain: the Young Finns study. Semin Arthritis Rheum 2013;42(6):640-50. [CrossRef] [PubMed]
Song E, Zhang C, Israelow B, Lu-Culligan A, Prado AV, Skriabine S, et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med 2021;218(3):e20202135. [CrossRef] [PubMed]
Tavčar P, Potokar M, Kolenc M, Korva M, Avšič-Županc T, Zorec R, et al. Neurotropic viruses, astrocytes, and COVID-19. Front Cell Neurosci 2021;15:662578. [CrossRef] [PubMed]
Teraguchi M, Hashizume H, Oka H, Cheung JP, Samartzis D, Tamai H, et al. Headache attributed to vaccination against COVID-19 (coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) vaccine: a multicenter observational cohort study. Pain Ther 2021;10(2):1309-30. [CrossRef] [PubMed]
Vera-Lastra O, Medina G, Cruz-Dominguez MD, Jara LJ, Shoenfeld Y, et al. Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld’s syndrome): clinical and immunological spectrum. Expert Rev Clin Immunol 2013;9(4):361-73. [CrossRef] [PubMed]
Wang VT, Odani T, Ito M. Considerations and strategies for restarting elective spine surgery in the midst of a pandemic of COVID-19. Spine Surg Relat Res 2021;5(2):52-60. [CrossRef] [PubMed]
Zeb A, Khurshid S, Bano S, Rasheed U, Zammurrad S, Khan MS, et al. The Role of the Neutrophil-to-Lymphocyte Ratio and Platelet-to- Lymphocyte Ratio as Markers of Disease Activity in Ankylosing Spondylitis. Cureus 2019;11(10):e6025. [CrossRef] [PubMed]
Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. JAMA Neurol 2020;77(8):1018-27. [CrossRef] [PubMed]
